Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13876
PUT
iShares US Infrastructure ETF
IFRA
$3.99B
| $4.63K | ﹤0.01% |
100
-100
| -50% | -$4.84K |
2024 Q2
2 quarters
|
|
13877
PUT
TH International
THCH
$38.4M
| $4.62K | ﹤0.01% |
+1,300
| New | +$4.93K |
2024 Q4
0 quarters
|
|
13878
PUT
Franklin FTSE Mexico ETF
FLMX
$80.3M
| $4.6K | ﹤0.01% |
+200
| New | +$5.09K |
2024 Q4
0 quarters
|
|
13879
CALL
SEACOR Marine Holdings
SMHI
$235M
| $4.59K | ﹤0.01% |
700
+100
| +17% | +$743 |
2022 Q4
8 quarters
|
|
13880
CALL
Center Bancorp
CNOB
$1.54B
| $4.58K | ﹤0.01% |
200
-1,600
| -89% | -$41.2K |
2024 Q2
2 quarters
|
|
|
AKYA
13881
PUT
DELISTED
Akoya BioSciences
AKYA
| $4.58K | ﹤0.01% |
+2,000
| New | +$5.3K |
2024 Q4
0 quarters
|
|
|
EONR.WS
13882
EON Resources Warrants
EONR.WS
$1.97M
| $4.58K | ﹤0.01% |
83,229
-2,996
| -3% | -$228 |
2024 Q3
1 quarter
|
|
|
MCHB
13883
CALL
Mechanics Bancorp
MCHB
$3.31B
| $4.57K | ﹤0.01% |
400
-5,200
| -93% | -$64.4K |
2022 Q4
8 quarters
|
|
13884
PUT
Nektar Therapeutics
NKTR
$1.43B
| $4.56K | ﹤0.01% |
327
-613
| -65% | -$10.8K |
2016 Q4
32 quarters
|
|
|
BRY
13885
PUT
DELISTED
Berry Corp
BRY
| $4.54K | ﹤0.01% |
1,100
-5,000
| -82% | -$23.1K |
2024 Q2
2 quarters
|
|
13886
CALL
Schwab US Aggregate Bond ETF
SCHZ
$10.4B
| $4.54K | ﹤0.01% |
200
| – | – |
2023 Q3
5 quarters
|
|
13887
CALL
Rani Therapeutics
RANI
$89.2M
| $4.52K | ﹤0.01% |
3,300
+800
| +32% | +$1.68K |
2024 Q1
3 quarters
|
|
13888
CALL
Exagen
XGN
$206M
| $4.51K | ﹤0.01% |
1,100
-3,400
| -76% | -$12.3K |
2023 Q4
4 quarters
|
|
13889
PUT
Gaia
GAIA
$35.6M
| $4.49K | ﹤0.01% |
+1,000
| New | +$5.47K |
2024 Q4
0 quarters
|
|
13890
PUT
Crown Crafts
CRWS
$26.6M
| $4.48K | ﹤0.01% |
+1,000
| New | +$4.62K |
2024 Q4
0 quarters
|
|
13891
CALL
Cambria Tail Risk ETF
TAIL
$147M
| $4.48K | ﹤0.01% |
400
-4,000
| -91% | -$46K |
2024 Q3
1 quarter
|
|
13892
PUT
ProShares Online Retail ETF
ONLN
$56.4M
| $4.47K | ﹤0.01% |
+100
| New | +$4.56K |
2024 Q4
0 quarters
|
|
|
ACCD
13893
CALL
DELISTED
Accolade Inc
ACCD
| $4.45K | ﹤0.01% |
1,300
-21,500
| -94% | -$76.4K |
2020 Q4
16 quarters
|
|
13894
PUT
E.W. Scripps
SSP
$251M
| $4.42K | ﹤0.01% |
+2,000
| New | +$4.62K |
2024 Q4
0 quarters
|
|
13895
Orion Energy Systems
OESX
$124M
| $4.41K | ﹤0.01% |
551
+447
| +430% | +$3.92K |
2023 Q3
5 quarters
|
|
13896
CALL
Pixelworks
PXLW
$42M
| $4.38K | ﹤0.01% |
+500
| New | +$4.53K |
2024 Q4
0 quarters
|
|
13897
CALL
TriCo Bancshares
TCBK
$1.67B
| $4.37K | ﹤0.01% |
100
-1,300
| -93% | -$59.2K |
2022 Q4
8 quarters
|
|
|
LYRA
13898
CALL
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $4.33K | ﹤0.01% |
420
-2
| -0.5% | -$22 |
2022 Q4
8 quarters
|
|
13899
CALL
Tango Therapeutics
TNGX
$3.87B
| $4.33K | ﹤0.01% |
1,400
-1,700
| -55% | -$7.89K |
2023 Q4
4 quarters
|
|
|
OMGA
13900
PUT
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $4.32K | ﹤0.01% |
5,800
-1,200
| -17% | -$1.2K |
2024 Q1
3 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.